Skip to main content
Premium Trial:

Request an Annual Quote

GeneExpress Reports, Topkat, GenBank Release 127.0

Premium

Gene Logic of Gaithersburg, Md., has released GeneExpress Reports, a pay-per-view approach to deriving focused data from its GeneExpress Suite of gene expression information.

The reports, which the company said can range from $25,000 to several hundred thousand dollars depending on the number of genes and tissue samples surveyed, are generated in response to specific queries keyed to individual genes of interest.

The company said that it has already signed on Vertex Pharmaceuticals, Athersys, Proteologics, Zycos, and an unnamed biopharmaceutical company as GeneExpress Reports customers.

 

Accelrys, the San Diego-based software subsidiary of Pharmacopeia, has released version 6.1 of Topkat, its program for the in silico estimation of toxicological properties of small molecules.

The new release includes Topkat Batch, which enables users to profile up to 1,000 compounds automatically. Topkat 6.1 also provides three new models for assessing a human therapeutic for potential toxicity: Rabbit Skin Irritancy, Rat Inhalation LC50, and Rat Maximum Tolerated Dose.

 

GenBank Release 127.0 is now available via FTP from the National Center for Biotechnology Information at ftp.ncbi.nih.gov.

Release 127.0 contains 15,849,921,438 base pairs and 14,976,310 entries, up by 1.453 billion base pairs and 1,374,048 sequence records from the October 126.0 release. According to the NCBI, these single-release increases are the second largest and the very largest in the database''s history, respectively.

Uncompressed, the 127.0 flat files require around 58.12 GB for the sequence files only while the ASN.1 version requires roughly 51.75 GB.

Filed under

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.